Denemek ALTIN - Özgür
The Revival Of Pharma MSMES
Express Pharma
|December 16-31, 2018
Effective implementation of the recently launched MSME Support and Outreach Programme could prove to be the catalyst for the sector's progress
The Modi government recently launched theMSME Support and Outreach Programme to boost the growth of the sector in India. Under the programme, the government has made various announcements and deliverables that focus on access to credit, access to market, hand holding and facilitation support measures etc. for the MSME sector.
The 12 point agenda With the launch of the programme, the government has also announced 12 point agenda for MSMEs. In its announcement, Prime Minister Narendra Modi said, “To resolve the issue of cash cycle in MSMEs, all companies with a turnover more than 500 crores, must now compulsorily be brought on the Trade Receivables e-Discounting System (TReDS). Joining this portal will enable entrepreneurs to access credit from banks, based on their upcoming receivables.”
1) Launch of 59-minute loan portal to enable easy access to credit for MSMEs. In principle approval of loans upto 1 crore through the portal. Portal link through GST portal.
2) Two per cent interest subvention for all GST registered MSMEs, on fresh or incremental loans. Increase in interest rebate from three to five per cent for exporters who receive loans in the pre-shipment and post-shipment period.
3) Companies with turnover more than 500 crores to be compulsorily brought on the Trade Receivables e-Discounting System (TReDS) to enable entrepreneurs to access credit, based on upcoming receivables.
4) Central Public Sector Undertaking (CPSUs) units to make mandatory procurement of 25 per cent instead of 205 from MSMEs.
5) CPSUs to make mandatory procurement of three per cent from women entrepreneurs out of 25 per cent mandatory procurement.
6) CPSUs to compulsorily be part of Public Procurement Portal GeM- Government e-Marketplace. CPSUs to get their vendors registered on GeM portal.
Bu hikaye Express Pharma dergisinin December 16-31, 2018 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Express Pharma'den DAHA FAZLA HİKAYE
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Translate
Change font size
